We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Characteristics and influencing factors of microplastics entering human blood through intravenous injection
AI summary Read the abstract
This study found that common medical devices used for intravenous injections -- syringes, infusion sets, and vein needles -- release microplastics directly into patients' bloodstreams. The dominant particles were polyethylene and polypropylene fragments, and repeated use of devices significantly increased the amount released. While the total number of particles entering the body this way is lower than from food, the direct injection into blood makes this exposure pathway especially concerning.
The presence of microplastics in the human body and their potential health risks have drawn widespread attention in recent years. Microplastics have been detected in human blood, though their pathways of entry remain unclear. This study employed Raman spectroscopy and energy dispersive spectroscopy to evaluate the microplastic release characteristics of intravenous medical devices, aiming to investigate the influencing factors and the risk of microplastics entering the bloodstream. The results showed that microplastics were found in three widely-used medical devices, with abundances ranging from 0.44 to 2.00 items/n. Polyethylene, polypropylene (46.2 %), fragments (96.7 %), and white (86.8 %) were the predominant characteristics. Factors such as brand, specifications, and usage scenarios influence microplastic release, leading to differences in detection rates among different medical devices (0-100%). Repeated use significantly increases the risk of microplastic release (p < 0.05). Notably, built-in filtration membranes do not completely retain microplastics and may pose a risk of shedding fibers themselves. Using the exposure assessment model, the estimated microplastic release per person per year was 3.75 items for syringe, 6.22 items for infusion set, and 0.35 items for vein detained needle. Overall, although the amount of microplastics entering the human body through intravenous injection is significantly lower than that from dietary exposure and other pathways, the risk of direct entry into the bloodstream remains a concern. This research provides critical evidence for understanding the direct pathways and risks of microplastic exposure in human blood from plastic medical devices, offering significant scientific value for assessing exposure pathways and the safety of medical device use.
More Papers Like This
Microplastics Entry into the Blood by Infusion Therapy: Few but a Direct Pathway
AI summary Read the abstract
Researchers tested infusion therapy equipment including glass bottles, plastic bottles, plastic bags, and tubes for microplastic contamination. They found microplastics in about 12% of samples, with particles ranging from 4 to 148 micrometers in size. Although the amounts were small, the study shows that IV infusions could be a direct route for microplastics to enter the bloodstream, which may partly explain why microplastics have been found in human blood.
MPs Entering Human Circulation through Infusions: A Significant Pathway and Health Concern
AI summary Read the abstract
This study measured the microplastics released by standard intravenous infusion equipment and found approximately 7,500 polypropylene particles per liter of fluid, with most particles between 1 and 20 micrometers in size. Standard filtration built into these medical devices does not fully prevent microplastic contamination. Since these particles enter the bloodstream directly, even small amounts could accumulate in organs like the liver, spleen, and lungs over time.
Factors affecting micro(nano)plastic release during intravenous therapy: Direct blood exposure.
AI summary Read the abstract
This study systematically evaluated factors affecting micro(nano)plastic (MNP) release from medical infusion products during intravenous therapy. Results indicated that MNPs are released into IV fluid at measurable levels, potentially delivering plastic particles directly into the bloodstream of patients.
Micro(nano)plastics (< 4 μm): An important but ignored concern during intravenous infusion
AI summary Read the abstract
Researchers found that common IV bags, tubes, and syringes release thousands of tiny plastic particles directly into the bloodstream during routine medical treatments. The particles, smaller than 4 micrometers, included types like PVC and polypropylene and were found in nearly all tested infusion products. This is a significant finding because it identifies a previously overlooked source of microplastic exposure that bypasses the body's natural barriers entirely.
Identification and quantification of micro–nano-plastics in polypropylene-bottled injections
AI summary Read the abstract
Researchers examined 16 batches of intravenous (IV) fluids packaged in polypropylene plastic bottles and found microplastic and nanoplastic particles in all of them, with concentrations reaching up to 10 million particles per milliliter. This is the first study to confirm that patients receiving IV infusions are being directly exposed to microplastics entering their bloodstream, though whether this causes harm remains to be studied.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.